BioPharma Credit PLC
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Market Cap & Net Worth: BioPharma Credit PLC (BOPCF)
BioPharma Credit PLC (PINK:BOPCF) has a market capitalization of $800.25 Million ($800.25 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #7847 globally and #4074 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioPharma Credit PLC's stock price $0.88 by its total outstanding shares 914252992 (914.25 Million).
BioPharma Credit PLC Market Cap History: 2018 to 2024
BioPharma Credit PLC's market capitalization history from 2018 to 2024. Data shows growth from $607.89 Million to $800.25 Million (4.95% CAGR).
BioPharma Credit PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioPharma Credit PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.43x
BioPharma Credit PLC's market cap is 6.43 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.55x
BioPharma Credit PLC's market cap is 6.55 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $607.89 Million | $78.72 Million | $70.15 Million | 7.72x | 8.67x |
| 2019 | $574.97 Million | $124.12 Million | $122.33 Million | 4.63x | 4.70x |
| 2020 | $598.10 Million | $95.96 Million | $89.14 Million | 6.23x | 6.71x |
| 2021 | $623.89 Million | $126.39 Million | $84.96 Million | 4.94x | 7.34x |
| 2022 | $661.83 Million | $213.77 Million | $182.31 Million | 3.10x | 3.63x |
| 2023 | $683.68 Million | $159.68 Million | $108.45 Million | 4.28x | 6.30x |
| 2024 | $800.25 Million | $124.46 Million | $122.18 Million | 6.43x | 6.55x |
Competitor Companies of BOPCF by Market Capitalization
Companies near BioPharma Credit PLC in the global market cap rankings as of March 19, 2026.
Key companies related to BioPharma Credit PLC by market ranking:
- Hiconics Drive Tech Co (SHE:300048): Ranked #7838 globally with a market cap of $879.16 Million USD ( CN¥6.45 Billion CNY).
- Sino Wealth Electronic Ltd (SHE:300327): Ranked #7839 globally with a market cap of $878.85 Million USD ( CN¥6.45 Billion CNY).
- Elders Ltd (AU:ELD): Ranked #7848 globally with a market cap of $877.73 Million USD ( AU$1.42 Billion AUD).
- Cadeler As (OL:CADLR): Ranked #7849 globally with a market cap of $877.51 Million USD ( Nkr10.00 Billion NOK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7838 | Hiconics Drive Tech Co | SHE:300048 | $879.16 Million | CN¥7.64 |
| #7839 | Sino Wealth Electronic Ltd | SHE:300327 | $878.85 Million | CN¥25.96 |
| #7848 | Elders Ltd | AU:ELD | $877.73 Million | AU$6.73 |
| #7849 | Cadeler As | OL:CADLR | $877.51 Million | Nkr57.75 |
BioPharma Credit PLC Historical Marketcap From 2018 to 2024
Between 2018 and today, BioPharma Credit PLC's market cap moved from $607.89 Million to $ 800.25 Million, with a yearly change of 4.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $800.25 Million | +17.05% |
| 2023 | $683.68 Million | +3.30% |
| 2022 | $661.83 Million | +6.08% |
| 2021 | $623.89 Million | +4.31% |
| 2020 | $598.10 Million | +4.02% |
| 2019 | $574.97 Million | -5.41% |
| 2018 | $607.89 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 19th, 2025 the market cap of BioPharma Credit PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $800.25 Million USD |
| MoneyControl | $800.25 Million USD |
| MarketWatch | $800.25 Million USD |
| marketcap.company | $800.25 Million USD |
| Reuters | $800.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.